Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 1, 2012, Pages 514-521

  Tsai, Shih Jei ^a,b   Huang, Chin Shiu ^c   Mong, Mei Chin ^c   Kam, Wing Yiu ^d   Huang, Hui Ying ^d   Yin, Mei Chin ^c,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

diabetes; naringenin; nuclear factor B; protein kinase C

Indexed keywords

ANTI-INFLAMMATORIES; ANTIFIBROTIC EFFECT; BLOOD UREA; CHEMOATTRACTANTS; CONTROL GROUPS; DIABETIC MICE; DIABETIC NEPHROPATHY; INTERLEUKIN1; MRNA EXPRESSION; NARINGENIN; NUCLEAR FACTORS; PLASMA LEVELS; PROTECTIVE EFFECTS; PROTEIN KINASE C; PROTEIN KINASE C ACTIVITIES; PROTEIN PRODUCTION; RENAL TUMORS; TRANSFORMING GROWTH FACTORS;

ENZYMES; GLUCOSE; MAMMALS; MEDICAL PROBLEMS; NITROGEN PLASMA; UREA;

PROTEINS;

ANTIINFLAMMATORY AGENT; FLAVANONE DERIVATIVE; INTERLEUKIN 6; NARINGENIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DIABETIC NEPHROPATHY; DISEASE MODEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; KIDNEY; MALE; METABOLISM; MOUSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FLAVANONES; HUMANS; INTERLEUKIN-6; KIDNEY; MALE; MICE; MICE, INBRED BALB C;

MUS;

EID: 84862914439     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf203259h     Document Type: Article

References (33)

1. Wang, S. N.; LaPage, J.; Hirschberg, R. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy Kidney Int. 2000, 57, 1002-1014 (Pubitemid 30434790)
2. Sahakyan, K.; Klein, B. E.; Lee, K. E.; Tsai, M. Y.; Klein, R. Inflammatory and endothelial dysfunction markers and proteinuria in persons with type 1 diabetes mellitus Eur. J. Endocrinol. 2010, 162, 1101-1105
3. Yamagishi, S.; Fukami, K.; Ueda, S.; Okuda, S. Molecular mechanisms of diabetic nephropathy and its therapeutic intervention Curr. Drug Targets 2007, 8, 952-959
4. Geerlings, S. E.; Brouwer, E. C.; van Kessel, K. C.; Gaastra, W.; Stolk, R. P.; Hoepelman, A. I. Cytokine secretion is impaired in women with diabetes mellitus Eur. J. Clin. Invest. 2000, 30, 995-1001
5. Tone, A.; Shikata, K.; Nakagawa, K.; Hashimoto, M.; Makino, H. Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients Clin. Exp. Nephrol. 2011, 15, 79-85
6. Sharma, K.; Ziyadeh, F. N.; Alzahabi, B.; McGowan, T. A.; Kapoor, S.; Kurnik, B. R.; Kurnik, P. B.; Weisberg, L. S. Increased renal production of transforming growth factor-β1 in patients with type II diabetes Diabetes 1997, 46, 854-859 (Pubitemid 27188264)
7. Hayashida, T.; Schnaper, H. W. High ambient glucose enhances sensitivity to TGF-β1 via extracellular signal-regulated kinase and protein kinase Cδ activities in human mesangial cells J. Am. Soc. Nephrol. 2004, 15, 2032-2041 (Pubitemid 39031342)
8. Mezzano, S.; Aros, C.; Droguett, A.; Burgos, M. E.; Ardiles, L.; Flores, C.; Schneider, H.; Ruiz-Ortega, M.; Egido, J. NF-κB activation and overexpression of regulated genes in human diabetic nephropathy Nephrol. Dial. Transplant. 2004, 19, 2505-2512 (Pubitemid 39360096)
9. Mulvihill, E. E.; Huff, M. W. Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can. J. Cardiol. 2010, Suppl. A) 17A-21A
10. Mulvihill, E. E.; Allister, E. M.; Sutherland, B. G.; Telford, D. E.; Sawyez, C. G.; Edwards, J. Y.; Markle, J. M.; Hegele, R. A.; Huff, M. W. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance Diabetes 2009, 58, 2198-2210
11. +-glucose cotransporter by naringenin Int. J. Biochem. Cell Biol. 2006, 38, 985-995 (Pubitemid 43363427)
12. Lin, W. C.; Lin, J. Y. Five bitter compounds display different anti-inflammatory effects through modulating cytokine secretion using mouse primary splenocytes in vitro J. Agric. Food Chem. 2011, 59, 184-192
13. Liu, X.; Wang, W.; Hu, H.; Tang, N.; Zhang, C.; Liang, W.; Wang, M. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-β1 in cultured rat hepatic stellate cells Pharm. Res. 2006, 23, 82-89 (Pubitemid 43214663)
14. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L. Protein determination with the Folin phenol reagent J. Biol. Chem. 1951, 193, 265-275
15. Cao, H.; Chen, X.; Sun, H.; Sakurai, T.; Zhou, J.; Sun, W.; Lv, H.; Wang, X. Pharmacokinetics-based elucidation on disparity in clinical effectiveness between varieties of Zhi Zhu Wan, a traditional Chinese Mmedical formula J. Ethnopharmacol. 2010, 128, 606-610
16. Sakata, N.; Meng, J.; Takebayashi, S. Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells J. Atheroscler. Thromb. 2000, 7, 169-176
17. Koya, D.; Haneda, M.; Nakagawa, H.; Isshiki, K.; Sato, H.; Maeda, S.; Sugimoto, T.; Yasuda, H.; Kashiwagi, A.; Ways, D. K.; King, G. L.; Kikkawa, R. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes FASEB J. 2000, 14, 439-447 (Pubitemid 30143162)
18. Ortiz-Andrade, R. R.; Sánchez-Salgado, J. C.; Navarrete- Vázquez, G.; Webster, S. P.; Binnie, M.; García-Jiménez, S.; León-Rivera, I.; Cigarroa-Vázquez, P.; Villalobos-Molina, R.; Estrada-Soto, S. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation Diabetes Obes. Metab. 2008, 10, 1097-1104
19. Kannappan, S.; Anuradha, C. V. Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome Eur. J. Nutr. 2010, 49, 101-109
20. Mohamed-Ali, V.; Armstrong, L.; Vlark, D.; Bolton, C. H.; Pinkney, J. H. Evidence for the regulation of levels of plasma adhesion molecules by inflammatory cytokines and their soluble receptors in type 1 diabetes J. Intern. Med. 2001, 250, 415-421 (Pubitemid 32989596)
21. Hatanaka, E.; Monteagudo, P. T.; Marrocos, M. S.; Campa, A. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes Clin. Exp. Immunol. 2006, 146, 443-447 (Pubitemid 44722162)
22. Martinovic, I.; Abegunewardene, N.; Seul, M.; Vosseler, M.; Horstick, G.; Buerke, M.; Darius, H.; Lindemann, S. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease Circulation J. 2005, 69, 1484-1489 (Pubitemid 41743963)
23. Cohen, M. P.; Sharma, K.; Guo, J.; Eltayeb, B. O.; Ziyadeh, F. N. The renal TGF-β system in the db/db mouse model of diabetic nephropathy Exp. Nephrol. 1998, 6, 226-233 (Pubitemid 28247581)
24. Ziyadeh, F. N.; Hoffman, B. B.; Han, D. C.; Iglesias-De La Cruz, M. C.; Hong, S. W.; Isono, M.; Chen, S.; McGowan, T. A.; Sharma, K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 8015-8020 (Pubitemid 30460765)
25. Schmid, H.; Boucherot, A.; Yasuda, Y.; Henger, A.; Brunner, B.; Eichinger, F.; Nitsche, A.; Kiss, E.; Bleich, M.; Gröne, H. J.; Nelson, P. J.; Schlöndorff, D.; Cohen, C. D.; Kretzler, M. European Renal cDNA Bank (ERCB) Consortium. Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy Diabetes 2006, 55, 2993-3003 (Pubitemid 44923635)
26. Sakai, N.; Wada, T.; Furuichi, K.; Iwata, Y.; Yoshimoto, K.; Kitagawa, K.; Kokubo, S.; Kobayashi, M.; Hara, A.; Yamahana, J.; Okumura, T.; Takasawa, K.; Takeda, S.; Yoshimura, M.; Kida, H.; Yokoyama, H. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy Am. J. Kidney Dis. 2005, 45, 54-65 (Pubitemid 40038045)
27. Liu, W.; Zhang, X.; Liu, P.; Shen, X.; Lan, T.; Li, W.; Jiang, Q.; Xie, X.; Huang, H. Effects of berberine on matrix accumulation and NF-κB signal pathway in alloxan-induced diabetic mice with renal injury Eur. J. Pharmacol. 2010, 638, 150-155
28. Hoffmann, A.; Natoli, G.; Ghosh, G. Transcriptional regulation via the NF-κB signaling module Oncogene 2006, 25, 6706-6716 (Pubitemid 44657847)
29. Sanchez, A. P.; Sharma, K. Transcription factors in the pathogenesis of diabetic nephropathy Expert Rev. Mol. Med. 2009, 11, e13
30. Toyoda, M.; Suzuki, D.; Honma, M.; Uehara, G.; Sakai, T.; Umezono, T.; Sakai, H. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy Kidney Int. 2004, 66, 1107-1114 (Pubitemid 39121016)
31. 2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-κB signal pathways in renal proximal tubule cells Am. J. Physiol. Renal Physiol. 2008, 294, F534-541
32. Felgines, C.; Texier, O.; Morand, C.; Manach, C.; Scalbert, A.; Régerat, F.; Rémésy, C. Bioavailability of the flavanone naringenin and its glycosides in rats Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279, 1148-1154
33. Bredsdorff, L.; Nielsen, I. L.; Rasmussen, S. E.; Cornett, C.; Barron, D.; Bouisset, F.; Offord, E.; Williamson, G. Absorption, conjugation and excretion of the flavanones, naringenin and hesperetin from α- rhamnosidase-treated orange juice in human subjects Br. J. Nutr. 2010, 103, 1602-1609